Phakomatosis Pigmentovascularis.
Tran C, Alward WLM.
Ophthalmol Glaucoma. 2021 May-Jun;4(3):250. doi: 10.1016/j.ogla.2021.03.003.
Ocular manifestations in phakomatosis pigmentovascularis: Current concepts on pathogenesis, diagnosis, and management.
Abdolrahimzadeh S, Pugi DM, de Paula A, Scuderi G.
Surv Ophthalmol. 2021 May-Jun;66(3):482-492. doi: 10.1016/j.survophthal.2020.10.002. Epub 2020 Oct 13.
Phakomatosis Pigmentovascularis: A Rare Disease.
Singh A, Chandan Y, Pazare AR.
J Assoc Physicians India. 2023 Dec;71(12):91-92. doi: 10.59556/japi.71.0419.
Phakomatosis pigmentovascularis type IIb.
Wang B, Yang M, Lv S, Xu N, Zhang Y, Wu S, Wang J, Li F.
J Dtsch Dermatol Ges. 2019 Nov;17(11):1179-1182. doi: 10.1111/ddg.13980.
Glaucoma in phakomatosis pigmentovascularis.
Teekhasaenee C, Ritch R.
Ophthalmology. 1997 Jan;104(1):150-7. doi: 10.1016/s0161-6420(97)30346-7.
Phakomatosis pigmentovascularis.
Van Gysel D, Oranje AP, Stroink H, Simonsz HJ.
Pediatr Dermatol. 1996 Jan-Feb;13(1):33-5. doi: 10.1111/j.1525-1470.1996.tb01184.x.
Phakomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature.
Fernández-Guarino M, Boixeda P, de Las Heras E, Aboin S, García-Millán C, Olasolo PJ.
J Am Acad Dermatol. 2008 Jan;58(1):88-93. doi: 10.1016/j.jaad.2007.08.012. Epub 2007 Nov 28.
Phakomatosis pigmentovascularis II A and II B: clinical findings in 24 patients.
Vidaurri-de la Cruz H, Tamayo-Sánchez L, Durán-McKinster C, Orozco-Covarrubias Mde L, Ruiz-Maldonado R.
J Dermatol. 2003 May;30(5):381-8. doi: 10.1111/j.1346-8138.2003.tb00403.x.
Phakomatosis pigmentovascularis IIb (phakomatosis cesioflammea) associated with the absence of infrarenal inferior vena cava.
Pan Y, Jiang X.
Int J Dermatol. 2021 May;60(5):647-649. doi: 10.1111/ijd.15334. Epub 2020 Dec 13.
Phakomatosis Pigmentovascularis with Atypical Sturge-Weber Syndrome, Glaucoma and Asymptomatic CNS Microcirculation Aberrations.
Kansal NK, Melanda H, Dhanta A, Kumari N.
Indian J Dermatol. 2022 Sep-Oct;67(5):608-610. doi: 10.4103/ijd.ijd_34_21.
